Bobak R. Azamian insider trades

Open-market stock purchases and sales by Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc, from SEC Form 4 filings since Oct 20, 2020.

Recent trades

DateStockTradeValue
Sep 4, 2026TARS Tarsus Pharmaceuticals, IncSold$641K
Sep 4, 2026TARS Tarsus Pharmaceuticals, IncSold$265K
Sep 2, 2026TARS Tarsus Pharmaceuticals, IncSold$801K
Jun 17, 2026TARS Tarsus Pharmaceuticals, IncSold$281K
Jun 17, 2026TARS Tarsus Pharmaceuticals, IncSold$335K
Mar 19, 2026TARS Tarsus Pharmaceuticals, IncSold$802K
Mar 18, 2026TARS Tarsus Pharmaceuticals, IncSold$802K
Mar 17, 2026TARS Tarsus Pharmaceuticals, IncSold$762K
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Dec 24, 2025TARS Tarsus Pharmaceuticals, IncSold$449K
Dec 24, 2025TARS Tarsus Pharmaceuticals, IncSold$46.5K
Dec 4, 2025TARS Tarsus Pharmaceuticals, IncSold (not open market)—

Companies traded

  • TARS Tarsus Pharmaceuticals, Inc: 88 sales, last Sep 4, 2026

Get free alerts when Bobak R. Azamian files a new trade →